Prosecution Insights
Last updated: April 19, 2026

Phanes Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17760394 Antibodies Conjugated with Fatty Acid Molecules and Uses Thereof MELCHIOR, JAMES RYLAND 1644 Final Rejection Aug 09, 2022
17755742 Bispecific Antibodies with Alternatively Matched Interchain Cysteines and Uses Thereof LUNDE, GRACE HENRY 1641 Non-Final OA May 06, 2022

Managing Phanes Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month